Growth Hormone Signaling + Metabolic Refinement
Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH), designed to stimulate the body’s natural production of growth hormone. Rather than replacing GH directly, it activates upstream signaling pathways — preserving physiological rhythm and regulation.
Originally approved for HIV-associated lipodystrophy, Tesamorelin has since drawn research interest for its role in visceral fat modulation, body composition refinement, and metabolic health optimization.
Functional Focus
Visceral Fat Reduction
Studied for its targeted impact on abdominal fat accumulation through endogenous GH stimulation.
Lean Mass Preservation
Supports maintenance of muscle integrity while improving body composition.
Metabolic Health
Associated with improved lipid profiles and enhanced insulin sensitivity in clinical research.
Neuroendocrine Support
Growth hormone pathways influenced by Tesamorelin may contribute to cognitive performance and sleep quality.
Physiologic GH Activation
Stimulates natural growth hormone release without exogenous hormone replacement.
Research Notes
Tesamorelin is FDA-approved for a specific medical indication. Its broader applications in metabolic optimization and age-related body composition changes continue to be explored in clinical research.
Administered via subcutaneous injection.
Use is limited to prescribed and research contexts.
Tesamorelin
Due to the nature of the products, no returns or exchanges can be accepted.